Jacob Odeberg
Oprichter bij Cytacoat AB
Profiel
Jacob Odeberg is the founder of Cytacoat AB.
He is currently the Director at Helicure AB and an Associate Professor at the Royal Institute of Technology.
Previously, he worked as the Deputy Director at The Kempe Foundation for the Prevention & Treatment.
Actieve functies van Jacob Odeberg
| Bedrijven | Functie | Begin |
|---|---|---|
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Directeur/Bestuurslid | - |
| Royal Institute of Technology | Corporate Officer/Principal | - |
| Cytacoat AB | Oprichter | 17-05-2011 |
Eerdere bekende functies van Jacob Odeberg
| Bedrijven | Functie | Einde |
|---|---|---|
The Kempe Foundation for the Prevention & Treatment
 The Kempe Foundation for the Prevention & Treatment Miscellaneous Commercial ServicesCommercial Services The Kempe Foundation for the Prevention and Treatment of Child Abuse and Neglect provides treatment and prevention programs for abused children. It offers clinical care, advocacy, research, education, and national and international work. The company was founded in 1976 and is headquartered in Aurora, CO. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
| Cytacoat AB | |
The Kempe Foundation for the Prevention & Treatment
The Kempe Foundation for the Prevention & Treatment Miscellaneous Commercial ServicesCommercial Services The Kempe Foundation for the Prevention and Treatment of Child Abuse and Neglect provides treatment and prevention programs for abused children. It offers clinical care, advocacy, research, education, and national and international work. The company was founded in 1976 and is headquartered in Aurora, CO. | Commercial Services |
